Task: Answer Verification
Input (English): Question: Does antenatal receipt of sulfadoxine-pyrimethamine exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum : clinical outcomes from the QuEERPAM study?
Answer: In this longitudinal study of malaria at delivery, the receipt of SP as IPTp did not potentiate PAM morbidity despite the increasing prevalence and fixation of SP-resistant P. falciparum haplotypes. Even when there is substantial resistance, SP may be used in modified IPTp regimens as a component of comprehensive antenatal care.
Output (English): no